Knott David M Jr
Sector Allocation
- Healthcare52.6%$99.5M
- Financials20.1%$38.0M
- Technology18.4%$34.9M
- Other7.5%$14.2M
- Materials0.4%$807,400
- Energy0.4%$690,647
- Industrials0.3%$532,280
- Real Estate0.2%$315,072
- Consumer Staples0.1%$275,656
- Consumer Discretionary0.0%$71,502
AUM History
13fpro.ai/research/fund/knott-david-m-jr-1892770
Conviction and streaks
Concentrating · top 10 = 62.8%From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.
Largest positions — Q2 2026
GOOG
$32.3MAPO
$26.6MSNDX
$9.6MXERS
$8.4MTVTX
$8.4MPTGX
$7.7MBBIO
$6.9MIOVA
$6.7MALKS
$6.4MJPM
$5.9M- Janus$4.7M
- LPL$4.6M
COGT
$4.3MTGTX
$3.7MCLST
$3.6MAGIO
$3.5MVRDN
$3.3MRLMD
$3.1MRCUS
$2.5MHELP
$2.4M
Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.
13fpro.ai/research/fund/knott-david-m-jr-1892770
Knott David M Jr 13F holdings — Q2 2026
$189.2M portfolio (+12.6% QoQ) · 84 holdings · Q2 2026 13F · top 10 are 63% of the stock portfolio
$32.3M
17.1% of stocks
No changeThis quarter-8.2%Since filed7+ qtrsHeld$26.6M
14.1% of stocks
No changeThis quarter-17.5%Since filed7+ qtrsHeld$9.6M
5.0% of stocks
+4%This quarter-33.2%Since filed7+ qtrsHeldAIQuality33.7#2,359Est. buyEstimated buy price is Pro: unlock with a free trialAdded 2 qtrs in a row$8.4M
4.4% of stocks
No changeThis quarter+20.3%Since filed7+ qtrsHeld$8.4M
4.4% of stocks
+5%This quarter-19.6%Since filed7+ qtrsHeld$7.7M
4.1% of stocks
No changeThis quarter-7.7%Since filed7+ qtrsHeld$6.9M
3.7% of stocks
+3%This quarter-18.7%Since filed5 qtrsHeldAIQualityAI quality score is Pro: unlock with a free trialEst. buyEstimated buy price is Pro: unlock with a free trialAdded 2 qtrs in a row$6.7M
3.5% of stocks
No changeThis quarter+104.5%Since filed2 qtrsHeld$6.4M
3.4% of stocks
+1%This quarter-11.6%Since filed5 qtrsHeldAIQualityAI quality score is Pro: unlock with a free trialEst. buyEstimated buy price is Pro: unlock with a free trialAdded 3 qtrs in a row$5.9M
3.1% of stocks
-7%This quarter-8.5%Since filed7+ qtrsHeld
All holdings — Knott David M Jr (Q2 2026)
84 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.
| # | Company | Held | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11 | — | Janus Henderson AAA CLO ETF - Commonetf/fund | — | $4.7M | 2.5% | 94K | — | — | — | 13F |
| 12 | — | LPL Financial Holdings Inc. - Common | — | $4.6M | 2.5% | 17K | — | — | — | 13F |
| 13 | Cogent Biosciences, Inc. | Healthcare | $4.3M | 2.3% | 111K | +7% | 3 qtrsAdded 3 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 14 | TG THERAPEUTICS, INC. | Healthcare | $3.7M | 1.9% | 67K | -26% | 3 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 15 | Catalyst Bancorp, Inc. | Financials | $3.6M | 1.9% | 114K | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 16 | AGIOS PHARMACEUTICALS, INC. | Healthcare | $3.5M | 1.9% | 95K | +2% | 3 qtrsAdded 3 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 17 | Viridian Therapeutics, Inc.\DE | Healthcare | $3.3M | 1.8% | 181K | — | 7+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 18 | RELMADA THERAPEUTICS, INC. | Healthcare | $3.1M | 1.6% | 451K | +3% | 2 qtrsAdded 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 19 | Arcus Biosciences, Inc. | Healthcare | $2.5M | 1.3% | 81K | — | 6 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 20 | Helus Pharma Inc. | Healthcare | $2.4M | 1.3% | 370K | +6% | 7+ qtrsAdded 4 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 21 | — | SPDR S&P Biotech ETF - Commonetf/fund | — | $2.4M | 1.3% | 15K | — | — | — | 13F |
| 22 | Rezolute, Inc. | Healthcare | $1.9M | 1.0% | 370K | — | 4 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 23 | ALLIANCEBERNSTEIN HOLDING L.P. | Financials | $1.7M | 0.9% | 48K | — | 7+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 24 | MADRIGAL PHARMACEUTICALS, INC. | Healthcare | $1.6M | 0.8% | 3,000 | +50% | 5 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 25 | AtriCure, Inc. | Healthcare | $1.4M | 0.8% | 51K | — | 6 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 26 | $DCGO | DocGo Inc. | Healthcare | $1.4M | 0.7% | 2.67M | — | |||
| 27 | $ARDX | ARDELYX, INC. | Healthcare | $1.3M | 0.7% | 263K | +27% | |||
| 28 | $RARE | Ultragenyx Pharmaceutical Inc. | Healthcare | $1.3M | 0.7% | 38K | +15% | |||
| 29 | — | The Panagram BBB-B CLO ETF - Common | — | $1.3M | 0.7% | 48K | — | |||
| 30 | $CGEM | Cullinan Therapeutics, Inc. | Healthcare | $1.3M | 0.7% | 69K | +186% | |||
| 31 | $JNJ | JOHNSON & JOHNSON | Healthcare | $1.3M | 0.7% | 4,922 | — | |||
| 32 | $VERA | Vera Therapeutics, Inc. | Healthcare | $1.1M | 0.6% | 26K | — | |||
| 33 | $OBIO | Orchestra BioMed Holdings, Inc. | Healthcare | $1.1M | 0.6% | 254K | — | |||
| 34 | $SPRB | SPRUCE BIOSCIENCES, INC. | Healthcare | $1.1M | 0.6% | 20K | New | |||
| 35 | $CNTB | Connect Biopharma Holdings Ltd | Healthcare | $1.1M | 0.6% | 445K | +15% | |||
| 36 | — | iShares Biotechnology ETF - Common | — | $1.0M | 0.6% | 5,500 | — | |||
| 37 | $BIIB | BIOGEN INC. | Healthcare | $864K | 0.5% | 4,000 | — | |||
| 38 | $PFE | PFIZER INC | Healthcare | $779K | 0.4% | 32K | — | |||
| 39 | $AAPL | Apple Inc. | Technology | $722K | 0.4% | 2,494 | — | |||
| 40 | $CNQ | CANADIAN NATURAL RESOURCES Ltd | Energy | $664K | 0.3% | 17K | — | |||
| 41 | $PTHS | Pelthos Therapeutics Inc. | Healthcare | $624K | 0.3% | 22K | +5% | |||
| 42 | $IBM | INTERNATIONAL BUSINESS MACHINES CORP | Technology | $602K | 0.3% | 2,142 | — | |||
| 43 | $MSFT | MICROSOFT CORP | Technology | $597K | 0.3% | 1,600 | — | |||
| 44 | $VSTM | Verastem, Inc. | Healthcare | $592K | 0.3% | 155K | +49% | |||
| 45 | $KURA | Kura Oncology, Inc. | Healthcare | $579K | 0.3% | 53K | — | |||
| 46 | $SLDB | Solid Biosciences Inc. | Healthcare | $562K | 0.3% | 56K | +19% | |||
| 47 | $DD | DuPont de Nemours, Inc. | Materials | $511K | 0.3% | 3,767 | — | |||
| 48 | $INSM | INSMED Inc | Healthcare | $453K | 0.2% | 4,253 | New | |||
| 49 | $LBRX | LB PHARMACEUTICALS INC | Healthcare | $421K | 0.2% | 13K | New | |||
| 50 | $CDNA | CareDx, Inc. | Healthcare | $388K | 0.2% | 14K | New | |||
| 51 | $QTTB | Q32 Bio Inc. | Healthcare | $387K | 0.2% | 30K | New | |||
| 52 | $ELVN | Enliven Therapeutics, Inc. | Healthcare | $314K | 0.2% | 6,183 | New | |||
| 53 | $RHP | Ryman Hospitality Properties, Inc. | Real Estate | $309K | 0.2% | 2,400 | — | |||
| 54 | $AVGO | Broadcom Inc. | Technology | $268K | 0.1% | 710 | — | |||
| 55 | $KMB | KIMBERLY CLARK CORP | Materials | $263K | 0.1% | 2,400 | — | |||
| 56 | $NVDA | NVIDIA CORP | Technology | $256K | 0.1% | 1,280 | — | |||
| 57 | $BSX | BOSTON SCIENTIFIC CORP | Healthcare | $256K | 0.1% | 6,000 | New | |||
| 58 | $WVE | Wave Life Sciences, Inc. | Healthcare | $232K | 0.1% | 40K | — | |||
| 59 | $RAIN | Rain Enhancement Technologies Holdco, Inc. | Industrials | $210K | 0.1% | 102K | — | |||
| 60 | $MDLZ | Mondelez International, Inc. | Consumer Staples | $174K | 0.1% | 3,000 | — | |||
| 61 | $PWR | QUANTA SERVICES, INC. | Industrials | $127K | 0.1% | 176 | — | |||
| 62 | $BMY | BRISTOL MYERS SQUIBB CO | Healthcare | $115K | 0.1% | 2,000 | -85% | |||
| 63 | $EBC | Eastern Bankshares, Inc. | Financials | $111K | 0.1% | 5,000 | — | |||
| 64 | $GOOGL | Alphabet Inc. | Technology | $107K | 0.1% | 300 | — | |||
| 65 | $LEGH | Legacy Housing Corp | Industrials | $105K | 0.1% | 4,000 | — | |||
| 66 | $CTVA | Corteva, Inc. | Consumer Staples | $102K | 0.1% | 1,206 | — | |||
| 67 | — | iShares Russell Mid-Cap Growth - Common | — | $102K | 0.1% | 695 | — | |||
| 68 | $URI | UNITED RENTALS, INC. | Industrials | $88K | 0.1% | 78 | — | |||
| 69 | $IVVD | Invivyd, Inc. | Healthcare | $87K | 0.1% | 100K | — | |||
| 70 | $AMZN | AMAZON COM INC | Consumer Discretionary | $72K | 0.0% | 300 | — | |||
| 71 | $DHR | DANAHER CORP /DE/ | Healthcare | $34K | 0.0% | 180 | — | |||
| 72 | $DOW | DOW INC. | Materials | $33K | 0.0% | 1,206 | — | |||
| 73 | $FSK | FS KKR Capital Corp | Other | $30K | 0.0% | 2,875 | — | |||
| 74 | $BRSL | Brightstar Lottery PLC | Communication Services | $27K | 0.0% | 2,500 | — | |||
| 75 | $BX | Blackstone Inc. | Financials | $25K | 0.0% | 210 | — | |||
| 76 | $UNH | UNITEDHEALTH GROUP INC | Healthcare | $24K | 0.0% | 57 | — | |||
| 77 | $OXY | OCCIDENTAL PETROLEUM CORP /DE/ | Energy | $23K | 0.0% | 469 | -29% | |||
| 78 | $TMO | THERMO FISHER SCIENTIFIC INC. | Healthcare | $23K | 0.0% | 45 | — | |||
| 79 | $CRM | Salesforce, Inc. | Technology | $12K | 0.0% | 77 | — | |||
| 80 | $STWD | STARWOOD PROPERTY TRUST, INC. | Real Estate | $7K | 0.0% | 400 | — | |||
| 81 | $KD | Kyndryl Holdings, Inc. | Technology | $5K | 0.0% | 428 | — | |||
| 82 | $OXY | OCCIDENTAL PETROLEUM CORP /DE/ | Energy | $4K | 0.0% | 194 | New | |||
| 83 | $GEHC | GE HealthCare Technologies Inc. | Healthcare | $3K | 0.0% | 50 | — | |||
| 84 | $WAB | WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP | Industrials | $2K | 0.0% | 6 | — |
What changed in Q2 2026
Against the previous quarter's 13F: 8 new, 16 added to, 4 trimmed, 10 sold out. Share-count changes; largest moves by dollar size first.
New positions (8)
first bought this quarter
$SPRBSPRUCE BIOSCIENCES, INC.$1.1M
first bought this quarter
$INSMINSMED Inc$453K
first bought this quarter
$LBRXLB PHARMACEUTICALS INC$421K
first bought this quarter
$CDNACareDx, Inc.$388K
first bought this quarter
$QTTBQ32 Bio Inc.$387K
first bought this quarter
+2 more in the Excel export
Added to (16)
$CGEMCullinan Therapeutics, Inc.+186%
now $1.3M · held 2 qtrs, 2 adds in a row
$MDGLMADRIGAL PHARMACEUTICALS, INC.+50%
now $1.6M · held 5 qtrs
now $8.4M · held 7+ qtrs
now $9.6M · held 7+ qtrs, 2 adds in a row
$ARDXARDELYX, INC.+27%
now $1.3M · held 2 qtrs, 2 adds in a row
now $4.3M · held 3 qtrs, 3 adds in a row
+10 more in the Excel export
Trimmed (4)
Sold out (10)
$CPRXCATALYST PHARMACEUTICALS, INC.was $3.0M
held 9+ qtrs
$ACLXArcellx, Inc.was $2.2M
held 5 qtrs
$CYTKCYTOKINETICS INCwas $1.6M
held 3 qtrs
$CNTACentessa Pharmaceuticals plcwas $1.5M
held 2 qtrs
$ADMAADMA BIOLOGICS, INC.was $542K
held 2 qtrs
- Biohaven Pharmaceutical Holding Co. Ltdwas $514K
+4 more in the Excel export
Holdings by quarter
Every 13F Knott David M Jr has filed, 18 earlier quarters. Pick one to see what it held then.
Is it too late to follow Knott David M Jr?
Q2 2026 13F filed with the SEC on Aug 12, 2026. Prices are closing prices as of Oct 26, 2026.
Average quality of Knott David M Jr's top 20 holdings: 53/100 (our AI quality score, weighted by position size; 14 of the 20 are scored)
Top 10 since filing
-5.6%
Value-weighted move of the 10 largest stock positions
Turnover
6%
Last quarter; 34% over the last 4
Top 10 weight
63%
Share of the stock portfolio in its 10 largest positions
Held 4+ quarters
81%
Share of portfolio value in positions held a year or more
Highest-quality names it owns(among its 100 largest positions)
The 8 highest-scoring companies in this portfolio are a Pro feature.
How these are measured
- Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
- Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
- Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q4 2024 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
- Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
- Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.
Portfolio Overview
Knott David M Jr disclosed 84 positions worth $189.2M in its Form 13F-HR for Q2 2026, led by $GOOG (Alphabet Inc.) at 17.1% of the equity portfolio, followed by $APO and $SNDX. During the quarter the fund opened 8 new positions and exited 10 — including a new stake in $CLST and a full exit from $CPRX. The portfolio is most concentrated in Healthcare (52.6% of disclosed assets). All figures are sourced directly from Knott David M Jr’s Form 13F-HR filing with the SEC under CIK 1892770.
Funds like this
managers whose biggest positions overlap Knott David M Jr'sBrowse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
AI-Powered Hedge Fund Analysis: Knott David M Jr
13F Pro is an AI hedge fund tracker and stock research platform. For Knott David M Jr (SEC CIK: 1892770), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Knott David M Jr's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.